Stockholm - Delayed Quote SEK

Q-linea AB (publ) (QLINEA.ST)

Compare
2.4250 0.0000 (0.00%)
At close: October 25 at 5:29 PM GMT+2

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.
NameTitlePayExercisedYear Born
Mr. Stuart Gander Chief Executive Officer -- -- 1978
Mr. Christer Samuelsson CFO & IR -- -- 1962
Mr. Henrik Jacobson Chief Operating Officer -- -- 1969
Ms. Ulrika Stolpe HR Manager -- -- 1967
Ms. Tiziana Di Martino Chief Medical Officer -- -- 1976
Mr. Thomas Fritz Chief Commercial Officer -- -- 1964
Mr. Anders Ljunggren Managing Director -- -- 1981
Ms. Victoria Lerneryd Manager of QA/RA -- -- 1984

Q-linea AB (publ)

Dag HammarskjOelds vAeg 52 A
Uppsala, 752 37
Sweden
46 1 84 44 36 10 https://qlinea.com
Sector:?
Healthcare
Industry:?
Medical Devices
Full Time Employees:?
99

Description

Q-linea AB (publ) engages in the development of instruments and consumables for infection diagnostics in the United Kingdom. The company offers ASTar, an antibiotic susceptibility testing system used for positive blood cultures; and in vitro diagnostics systems for infectious diseases. It serves healthcare providers. The company was incorporated in 2007 and is headquartered in Uppsala, Sweden.

Corporate Governance

Q-linea AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

October 31, 2024 at 10:59 AM UTC

Q-linea AB (publ) Earnings Date

Recent Events

July 11, 2024 at 11:00 AM UTC

Half Year 2024 Q linea AB Earnings Call

Related Tickers